Difference between revisions of "Part:BBa I712004"
Chenchenzhu (Talk | contribs) (→Functional Parameters) |
Chenchenzhu (Talk | contribs) (→Functional Parameters) |
||
Line 20: | Line 20: | ||
|-valign="top" border="0" | |-valign="top" border="0" | ||
|width="450px" style="padding: 0 20px 0 0;"| | |width="450px" style="padding: 0 20px 0 0;"| | ||
− | [[Image:HD09_CMV_standard3.png|center|350px|thumb|<div style="text-align:justify;">'''Fig. | + | [[Image:HD09_CMV_standard3.png|center|350px|thumb|<div style="text-align:justify;">'''Fig. 6: Strength of the CMV promoter in different cell lines in REU'''. [http://2009.igem.org/Team:Heidelberg/Project_Measurement Relative Expression Units (REU)] were determined by three independent flow cytometry measurements on three different days. This measurement was confirmed by an independent technique - image analysis.</div>]] |
|width="450px"| | |width="450px"| | ||
[[Image:HD09_FACS_cmv_medium_with_time.PNG|center|400px|thumb| '''Figure 2: CMV strength changes depending on conditions''' As [http://2009.igem.org/Team:Heidelberg/Project_Measurement#Identification_of_challenges_unique_to_higher_eukaryotes there are no truly constitutive promoters in mammalian cells], both the reference promoter ([[Part:BBa_K203112]]) and CMV fluctuate dependent on condition (Erolimus induces extreme starvation). Measured by Flow cytometry 20 hours after transfection (unless specified otherwise).]] | [[Image:HD09_FACS_cmv_medium_with_time.PNG|center|400px|thumb| '''Figure 2: CMV strength changes depending on conditions''' As [http://2009.igem.org/Team:Heidelberg/Project_Measurement#Identification_of_challenges_unique_to_higher_eukaryotes there are no truly constitutive promoters in mammalian cells], both the reference promoter ([[Part:BBa_K203112]]) and CMV fluctuate dependent on condition (Erolimus induces extreme starvation). Measured by Flow cytometry 20 hours after transfection (unless specified otherwise).]] |
Revision as of 19:38, 21 October 2009
CMV promoter
a constitutive expression promoter for use in mammalian cells. Ribosome binding site is included.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Functional Parameters
negative_regulators | -NA- |
positive_regulators | -NA- |
[http://2009.igem.org/Team:Heidelberg Heidelberg 2009 iGEM team] characterized this promoter in Part:BBa_K203100 as a first application for its newly developed units of promoter strength in mammalian cells, [http://2009.igem.org/Team:Heidelberg/Project_Measurement Relative Expression Units (REU)] and [http://2009.igem.org/Team:Heidelberg/Project_Measurement Relative Mammalian Promoter Units (RMPU)], where RMPU is directly proportional to PoPs and measured on a RNA level, whereas REU is measured on the protein level. We found CMV to have a strength of 5,52 REU (Standard Error of the Mean = 0,60) in [http://2009.igem.org/Team:Heidelberg/Eucaryopedia#HeLa HeLa cells], 6,57 (SEM = 0,91) in [http://2009.igem.org/Team:Heidelberg/Eucaryopedia#MCF-7 MCF-7 cells] and 9,96 (SEM = 1,52) in [http://2009.igem.org/Team:Heidelberg/Eucaryopedia#U2-OS U2-OS cells] cells (Fig 1). We furthermore found that CMV is not a truly constitutive promoter (but we [http://2009.igem.org/Team:Heidelberg/Project_Measurement#There_are_no_truly_constitutive_promoters_in_mammalian_cells argue] that no such promoter exists). In [http://2009.igem.org/Team:Heidelberg/Project_Measurement RMPU] (a mRNA-based unit directly proportional to PoPs), CMV has an activity of approx. 2.89 RPMU in HeLa cells,as measured by qRT-PCR (Fig. 3)